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The effect of Hibiscus sabdariffa L. (Hs) calyx extract on fat absorption-excretion and body weight in rats, was investigated. Rats
were fed with either a basal diet (SDC = Control diet) or the same diet supplemented with Hs extracts at 5%, 10% and 15% (SD5 ,
SD10 and SD15 ). Only SD5 did not show significant increases in weight, food consumption and efficiency compared to SDC . The
opposite occurred in SD15 group which showed a significant decrease for these three parameters. The SD10 responses were similar
to SD15, with the exception of food consumption. In both SDC and SD5 groups, no body weight loss was observed; however, only in
the latter group was there a significantly greater amount of fatty acids found in feces. A collateral effect emerging from the study is
that components of Hs extract at the intermediate and greater concentrations used in this experiment could be considered possible
antiobesity agents.
Copyright © 2009 O. Carvajal-Zarrabal et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
The scientific groups carrying out studies on Hibiscus
sabdariffa L. family Malvaceae calyx ethanol extract in order
to ascertain its physiological activity-structure relationship
are generally located in areas where it is used in food
applications and traditional medicine [1]. Advances in these
studies can be divided into three lines: therapeutic effects
on lipid metabolism [2–8]; antihypertensive effects [9–13];
apoptotic effects in gastric carcinoma cells [14, 15]. In several
of the studies, [2, 4, 6, 8–11, 13] no extract standardization is
reported, although a tendency is observed to overcome this
deficiency. Besides the calyx, H. sabdariffa L. leaf has also
been subjected to this type of scientific studies, particularly
leaf ethanolic extracts, which have been found to influence
lipid metabolism [16–20].
Hs calyx extract contains hibiscus acid, or (+)-hydro-
xycitric acid, known as (+)-HCA [21–23]. Its isomer,
(−)-hydroxycitric acid or (−)-HCA, the active ingredient
principle present in Garcinia indica and Garcinia cambogia
fruits, is an inhibitor of citrate lyase [24, 25], and because
of this, it has been proposed as an anti-obesity agent [25–
30]. Tee et al. [31] reported that hydroxycitric acid (no
isomer specified), present in Hs calyx extract, inhibits fat
production from carbohydrates in experiments carried out
on rats. In addition, Carvajal-Zarrabal et al. [6] suggested
that racemization of (+)-HCA to (−)-HCA by the intestinal
flora may be a possible explanation to warrant the significant
decrease in triacylglycerols in the experiment carried out
on rats supplemented with Hs extract. This proposal agrees
with the generalization made by Borriello et al. [32], which
establishes that phytochemicals absorbed in the intestine
can be transformed by colonic bacteria, resulting in serum
components different from the original phytochemicals.
Therapeutic effects reported in studies carried out on
animal models supplemented with Roselle, Hibiscus sabdar-
iffa L. extracts include its influence on lipid metabolism as
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Table 1: Composition of basal and experimental diets. Experimen-
tal diets are Basal diet plus Hibiscus sabdariffa ethanol calyx extract
(Diet formulated according to AIN-93 G formulation)






Mineral mix AING-93 G 3.5







well as its antihypertensive and apoptotic actions. The aim
of the present study was to research the action of Hs calyx
extract on fat absorption, excretion, and body weight, as no
information was encountered referring specifically to these
aspects of lipid metabolism.
2. Materials and Methods
2.1. Plant Material and Extract Preparation. The air dried
calyces along with a sample of the flowering plant of
Hibiscus sabdariffa were acquired from the local market in
Veracruz, Mexico. The sample was authenticated as Hibiscus
sabdariffa L. by Prof. Sergio Avendaño and registered as
O.Carvajal 001 at the Herbarium of the Ecology Institute
A.C., Xalapa, Veracruz. Mexico. The calyces (135 g) were
placed in a flask and 500 mL (96%) ethanol were added.
The content was left for 8 days, with an occasional shaking
to increase the extraction capacity. The macerated substance
was filtered and concentrated in a rotary evaporator at 38 ◦C .
The solid mass obtained from the evaporated extract was
approximately 7.5% w/v. The concentrated plant extract was
stored at 4 ◦C until used. Its viscosity at 25 ◦C was 1200 c.p.
2.2. Animals and Diets. The experimental protocol for
animal experiments was approved by the Animal Ethic
Committee, Chemical-Biology Area, University of Veracruz
(Program: Hibiscus sabdariffa Part I 2004–2008). Forty Male
Sprague-Dawley rats (6 weeks old, 250 to 350 g in weight)
were purchased from Harlan Teklad, Co. (Mexico City)
and individually housed in stainless steel mesh cages in
a temperature-controlled room (22–25 ◦C regulated by an
electronic timer) with a 12-hours light/dark cycle. They had
free access to food and non-ionized water throughout the
feeding period. The basal diet was prepared according to
the American Institute of Nutrition [33] and is shown in
Table 1. Lard (10 g/100 g diet) was employed as the source
of dietary fat, and cholesterol and cholic acid were added
at 1 and 0.25 g/100 g diet, respectively. The experimental
diet is the basal diet plus ethanol dried extract of Hibiscus
sabdariffa calyces at levels of 5, 10, and 15 g of extract/100 g
diet. Animals were fed the basal diet for one week in order to
develop an atherogenic condition (cholesterol ≥ 220 mg/dL,
atherogenic index defined as total cholesterol, cHDL/cHDL
≥ 2.5). Thereafter, they were divided into four groups (10
rats each). The control group (SDC) was maintained on
the basal diet and three groups of rats, designated as SD5,
SD10, SD15, received the respective experimental diet for
4 weeks. The parameters that were quantified are directly
related to the digestive process and its effects; as this lasts
approximately 3 hours, its effect on body weight can be
measured with confidence and reproducibility within an
experimental period of 4 weeks. Diets were prepared once
a week and stored in powdered form at 4◦C until feeding.
Body weight and food intake were measured daily. Feces were
collected during the last 5 days and freeze-dried. At the end
of the experimental period, diets were withdrawn for at least
four hours.
2.3. Determination of Fat in Feces. Fecal fats were extracted
according to the method of Jeejeebhoy et al. [34]. Briefly,
1 g freeze-dried feces was acidified with 2 drops concentrated
HCl to release free fatty acids, and sequentially extracted with
solvent No.1 (heptane: diethyl ether: 95% ethanol = 1 : 1 :
1) and solvent No.2 (heptane: diethyl ether: 95% ethanol:
water=1 : 1 : 1 : 1). The lipid extract was vacuum dried
(Gallenkamp Oven Mod. UAF- 570-0300) and weighed. The
apparent absorption rate (%) of dietary fat was calculated
as 100 x [amount of daily fatty acid intake – amount
of fecal fatty acids excreted]/[amount of daily fatty acid
intake]. To identify the individual fatty acids excreted into
the feces, the lipid extract was saponified with an ethanol-
KOH solution, and the saponified fatty acids were acidified
with an HCl solution, diluted with an equal volume of H2O,
and methylated with an H2SO4/MeOH solution (1 : 115) as
described by Ikeda et al. [35]. Fatty acids were determined
by gas chromatography (Hewlett Packard 5890, Palo Alto,
CA.) with pentadecanoic acid as an internal standard. All
chemicals used were analytical grade.
2.4. Statistical Analysis. The obtained data were expressed
as mean ± standard deviation of means (x ± SD). A one-
way analysis of variance (ANOVA) was used to compare
the means of the studied groups with post hoc Duncan
multiple range tests at 5% and 1% for those results where
a significant difference was indicated. Minitab version 12
statistical software was used.
3. Results
3.1. Atherogenic Condition, Growth, and Diet Consump-
tion Parameters. Animals fed the basal diet attained an
atherogenic condition, their levels of cholesterol and their
atherogenic index being 481 ± 82 mg/dL and 6.1, respec-
tively. Table 2 shows growth, food consumption, and weight
parameters for both the control group SDC and the three
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Table 2: Growth parameters and fecal weight in rats treated with Hibiscus sabdariffa L. extract, A one-way analysis of variance (ANOVA)
was used to compare the means of the studied groups with post hoc Duncan multiple range tests at 5% and 1% for those results where a
significant difference was indicated.
Parameters
Dietary groups
Control (SDC) SD5 SD10 SD15
Initial body weight (g) 260 ± 7 261 ± 11 338 ± 10 261 ± 2
Final body weight (g) 307 ± 9 306 ± 11 356 ± 11 267 ± 4
Body weight gain (g) 47 ± 7 45 ± 5 18 ± 4∗∗ 6 ± 2∗∗
Food intake (g/d) 14.5 ± 0.3 14.2 ± 0.8 13.8 ± 0.6 12.1 ± 1.1∗
Food efficiency (g body weight gain/g food intake) 3.2 ± 0.6 3.2 ± 0.3 1.3 ± 0.3∗ 0.5 ± 0.2∗∗
Fecal dry weight (g/d) 1.25 ± 0.08 1.42 ± 0.12∗ 0.81 ± 0.05∗∗ 0.75 ± 0.09∗∗
Statistical differences (∗P < .05; ∗∗P < .01), when compared with the control group.
Table 3: Apparent fat absorption and fecal fat excretion in rats fed with H. sabdariffa L. extract, A one-way analysis of variance (ANOVA)
was used to compare the means of the studied groups with post hoc Duncan multiple range tests at 5% and 1% for those results where a
significant difference was indicated.
Parameters
Dietary groups
Control SDC SD5 SD10 SD15
Fatty acid absorption (%) 95.1 ± 0.31 91.4 ± 1.01∗∗ 93.6 ± 1.83 95.2 ± 0.89
Fatty acid excretion (μmol/d)
14 : 0 7 ± 1 12 ± 1 5 ± 1∗∗ 5 ± 1∗∗
16 : 0 20 ± 4 396 ± 40∗∗ 140 ± 7∗ 89 ± 6∗
16 : 1 8 ± 1 10 ± 1 9 ± 1 9 ± 1
18 : 0 289 ± 97 437 ± 58∗∗ 55 ± 5∗∗ 33 ± 5∗∗
18 : 1 8 ± 1 62 ± 9∗∗ 17 ± 2∗ 14 ± 1∗
18 : 2 (n-6) 9 ± 1 18 ± 2∗∗ 18 ± 2∗∗ 18 ± 1∗∗
Statistical differences (∗P < .05; ∗∗P < .01), when compared with the control group.
experimental groups supplemented with Hs extract (SD5,
SD10, and SD15). No significant differences were observed
between the experimental groups and control as regards body
weight; however, body weight gain in SD10 and SD15 groups
was significantly less (P < .01) than in control group SDC.
Food consumption in the experimental groups (SD5, SD10,
SD15) decreased with Hs extract dose, but this only became
significant (P < .05) in the SD15 group. Food efficiency for
the SD5 group was the same as for control SDC; however,
for SD10 and SD15 groups, a significant decrease in this
parameter was observed (P < .05 and P < .01, resp.)
compared to control. Feces weight (g/d) in all experimental
groups varied significantly compared to the control, with a
significant increase (P < .05) observed in the SD5 treated
group and a significant decrease (P < .01) in the SD10 and
SD15 treated groups.
3.2. Apparent Fecal Fat Absorption and Excretion. The results
shown in Table 3 reflect the effect of the diet the animals
were subjected to in this study, concerning fat absorption and
excretion. In the case of SD5, fat absorption was significantly
lower (P < .01) compared to control group SDC. A tendency
toward higher excretion was observed in the fecal fatty acid
profiles of experimental groups, as compared to control.
Specifically, SD5 group showed an increase for all fatty acids
in feces, significantly so for 16:0 (palmitic), 18 : 0 (stearic),
18 : 1 (oleic), and 18 : 2 (n-6) (linoleic). Fatty acids measured
in groups SD10 and SD15 showed an increase in four cases:
16 : 0 (palmitic), 16 : 1 (palmitoleic), 18 : 1 (oleic), and 18
: 2 (n-6) (linoleic); only for palmitoleic was the increase not
significant.
4. Discussion
Both experimental (SD5, SD10, and SD15) and control (SDC)
groups were fed ad libitum. Only SD5 group did not show a
significant difference in the three parameters studied: weight
gain, food consumption, and efficiency, as compared to
control. These results were different between groups SD5
and SD15, SD5 showing behavior similar to control, while
in SD15 a significant decrease in all three parameters was
observed. SD10 was similar to SD15, except in the case of
food consumption. Considering food efficiency comprises
both weight gain and food consumption, and that, as a
result, dietary components and their effect on body weight
are related; it is evident that Hs extracts, at intermediate and
greater concentrations used in these experiments (SD10 and
SD15), by not increasing body weight, reveal themselves as
potential antiobesity agents.
On the other hand, the SD5 group absorbed the least
amount of fat, exhibited an increase in all fatty acids in feces
resulting from fat hydrolysis, and did not lose weight, the
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latter behavior being similar to control. Fatty acid excretion
in SDC, however, was less than in SD5 group. One possible
explanation for this behavior in control and SD5 groups,
where weight gain was similar though with differential
lipid excretion, could be due to weight gain in SD5 group
basically through carbohydrate absorption; this assumes that
Hs extract components at this level of concentration do not
exert an inhibitory effect on pancreatic amylase.
Lower weight gain in SD10 and SD15 groups, added
to their similar total lipid absorption, though different in
excreted fatty acid type (greater palmitic, oleic, and linoleic
and lower stearic acids as compared to control) seems to
indicate that at these concentrations Hs extract components
could inhibit pancreatic amylase, as reported by Hansawasdi
et al. [36, 37], who identified Hibiscus acid, or (+)-HCA, as
responsible for this action. This would consequently prevent
polysaccharide unfolding and absorption. Mention should
be made of the significant decrease in food consumption
observed in the SD15 group, possibly related to a dietary
palatability problem when Hs extract concentration was
increased. Significantly increased C16:0 excretion, observed
in all groups, is attributable to Hs extract chemical com-
ponents. It is relevant to recall that the fat administered in
this experiment was lard, rich in triacylglicerols with C16:0
in sn-2 position. Renaud et al. [38] observed that C16:0
interesterification in fat triacylglycerols results in a greater
fat secretion in experimental animal feces accompanied by
a decrease in TAG and cholesterol levels, including HDL
cholesterol. We consider that this result is due to, amongst
other factors, the specificity of lingual and gastric lipases
which hydrolyse esters in positions 1 and 3, the latter being
twice as susceptible as the former. In order to explain the
effect of Hs extract chemical components, in their original
state or modified by the intestinal flora, on increased C16:0
concentration (20, 7, and 4.5 times in SD5, SD10, and SD15,
respectively, compared to SDC), as observed in the present
study of fecal fat, the following hypotheses are proposed:
inactivation of lipases; impediment of 2-monoacylglycerol
uptake into the enterocyte, due to a competitive saturation
of the specific transport system [39], or interesterification
of the C16:0 from sn-2 to sn-1 or sn-3. Validation of these
hypotheses requires further study.
It can be concluded that animals kept on a diet sup-
plemented with Hs calyx ethanol extract showed significant
C16:0 excretion in feces. The three hypotheses proposed
to explain this excretion need subsequent testing and
validation. Besides, a collateral effect emerging from the
study is that Hs extract components at the intermediate
and greater concentrations used in this experiment could
be considered possible anti-obesity agents, through their
tendency to inhibit α-amylase.
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Greenfield, and C. Nuñez, “Garcinia cambogia (hydroxycitric
acid) as a potential antiobesity agent: arandomized controlled
trial,” Journal of the American Medical Association, vol. 280, no.
18, pp. 1596–1600, 1998.
[27] K. Hayamizu, Y. Ishii, I. Kaneko, et al., “Effects of long-term
administration of Garcinia cambogia extract on visceral fat
accumulation in humans: a placebo-controlled double blind
trial,” Journal of Oleo Science, vol. 50, pp. 805–812, 2001.
[28] K. Hayamizu, T. Ishii, I. Kaneko, et al., “No-Observed-
Adverse-Effect Level (NOAEL) and sequential-high-doses
administration study on Garcinia cambogia extract in
humans,” Journal of Oleo Science, vol. 51, no. 4, pp. 365–369,
2002.
[29] K. Hayamizu, Y. Ishii, I. Kaneko, et al., “Effect of Garcinia
cambogia (hydroxicitric acid) on visceral fat accumulation: a
double-blind, randomized, placebo-controlled trial,” Current
Therapeutic Research, vol. 64, pp. 551–567, 2003.
[30] K. Hayamizu, Y. Ishii, N. Shigematsu, et al., “Safety of Garcinia
cambogia extract in healthy men: high-doses administration
study,” Journal of Oleo Science, vol. 52, pp. 499–504, 2003.
[31] P. L. Tee, S. Yusof, S. Mohamed, and N. A. Umar, “Mustapha,
effect of roselle (Hibiscus sabdariffa L.) on serum lipid of
sprague dawley rats,” Nutrition and Food Science, vol. 32, pp.
190–196, 2002.
[32] S. P. Borriello, K. D. R. Setchell, M. Axelson, and A. M. Lawson,
“Production and metabolism of lignans by the human faecal
flora,” Journal of Applied Bacteriology, vol. 58, no. 1, pp. 37–43,
1985.
[33] P. G. Reeves, F. H. Nielsen, and G. C. Fahey Jr., “AIN-
93 purified diets for laboratory rodents: final report of the
american institute of nutrition ad hoc writing committee on
the reformulation of the AIN-76A rodent diet,” Journal of
Nutrition, vol. 123, no. 11, pp. 1939–1951, 1993.
[34] K. N. Jeejeebhoy, S. Ahmad, and G. Kozak, “Determination of
fecal fats containing both medium and long chain triglycerides
and fatty acids,” Clinical Biochemistry, vol. 3, no. 1, pp. 157–
163, 1970.
[35] I. Ikeda, H. Yoshida, M. Tomooka, et al., “Effects of long-term
feeding of marine oils with different positional distribution
of eicosapentaenoic and docosahexaenoic acids on lipid
metabolism, eicosanoid production, and platelet aggregation
in hypercholesterolemic rats,” Lipids, vol. 33, no. 9, pp. 897–
904, 1998.
[36] C. Hansawasdi, J. Kawabata, and T. Kasai, “α-amylase
inhibitors from roselle (Hibiscus sabdariffa Linn.) tea,” Bio-
science, Biotechnology and Biochemistry, vol. 64, no. 5, pp.
1041–1043, 2000.
[37] C. Hansawasdi, J. Kawabata, and T. Kasai, “Hibiscus acid as an
inhibitor of starch digestion in the Caco-2 cell model system,”
Bioscience, Biotechnology and Biochemistry, vol. 65, no. 9, pp.
2087–2089, 2001.
[38] S. C. Renaud, J. C. Ruf, and D. Petithory, “The positional
distribution of fatty acids in palm oil and lard influences their
biologic effects in rats,” Journal of Nutrition, vol. 125, no. 2, pp.
229–237, 1995.
[39] K. Murota and J. Storch, “Uptake of micellar long-chain fatty
acid and sn-2-monoacylglycerol into human intestinal Caco-
2 cells exhibits characteristics of protein-mediated transport,”
Journal of Nutrition, vol. 135, no. 7, pp. 1626–1630, 2005.










Hindawi Publishing Corporation 
http://www.hindawi.com













Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Bioinformatics
Advances in
Marine Biology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Signal Transduction
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Evolutionary Biology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Biochemistry 
Research International
Archaea
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Genetics 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporation
http://www.hindawi.com
Nucleic Acids
Journal of
Volume 2014
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Enzyme 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Microbiology
